• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Childhood exposure to paracetamol not directly associated with increased asthma risk

byDaniel FisherandRavi Shah
November 30, 2014
in Chronic Disease, Pediatrics, Pulmonology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. This meta-analysis could not conclusively attribute increased asthma risk to in utero or early life paracetamol exposure.

2. While initial analysis showed an association between paracetamol exposure and asthma risk, controlling for coincident upper respiratory tract infections negated the association.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Recent evidence has suggested that the early life environment may confer risk of developing asthma in pediatric populations. Some studies have suggested that exposure to paracetamol (acetaminophen) in utero or during the first two years of life may increase asthma risk. This study pooled results from cohort studies of paracetamol exposure during the first trimester to 2 years of life and asthma prevalence at 5 or more years of age. While a small increase in asthma risk was found during all three trimesters of in utero and two years post-natal paracetamol exposure, the association between exposure and risk of asthma was not significant when controlling for coincident upper respiratory tract infections. In addition, heterogeneity between studies precluded any clear risk that could be attributed to solely paracetamol exposure.

While this study attempted to conclusively assess the effect of early life paracetamol exposure on asthma, the lack of suitably rigorous studies and randomized controlled trials made this task difficult. Of note, this study was particular in its inclusion/exclusion criteria in only accepting cohort studies, making the conclusion that exposure likely does not increase asthma risk very plausible. A well-designed prospective cohort study with clearly defined exposure data and later asthma development (>5 years) would be of great benefit to support this meta-analysis’s findings.

Click to read the study, published today in Archives of Disease in Childhood

RELATED REPORTS

The Scan by 2 Minute Medicine®: Leucovorin autism update, Oura Ring FDA scrutiny, Lilly oral GLP-1 trial, and Florida vaccine mandate repeal

Tylenol in the Spotlight: Pregnancy, Autism, and Evolving Guidance on Acetaminophen use

Relevant Reading: Prenatal paracetamol exposure and asthma: further evidence against confounding

In-Depth [meta-analysis]: Of the 1192 citations identified on the topic, only retrospective and prospective cohort studies that assessed paracetamol exposure before the 2nd year of life (including in utero) and assessed asthma development after at least 5 years of age were included in the analysis. Studies measuring wheezing as an endpoint were excluded, and only 11 studies were used for the subsequent analysis. Odds ratios of asthma risk at different exposure time points were, for first trimester 1.39 (CI95% 1.01-1.91), second trimester 1.17 (CI95% 1.04-1.31), third trimester 1.49 (CI95% 1.37-1.63), and during infancy 1.15 (CI95% 1.00-1.31). However, after adjusting or upper respiratory tract infections, the odds ratio of asthma risk during infancy fell to 1.06 (CI95% 0.90 to 1.22). While only 1 study assessed upper respiratory tract infections during pregnancy, the attenuation of risk was similar to those found during infancy.

More from this author: Shift impact cognition, but likely not permanent; Second hand fine particulates dangerously elevated in smoking homes; Suicide tourism in Switzerland; Decreased facial expression variability linked with serious cardiac disease; HIV infection may protect against multiple sclerosis

Image: CC/Wiki

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: tylenol
Previous Post

Nanoparticles may reduce impact of neurological injury [PreClinical]

Next Post

Patient Basics: Panic Disorder

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Obstetrics

The Scan by 2 Minute Medicine®: Leucovorin autism update, Oura Ring FDA scrutiny, Lilly oral GLP-1 trial, and Florida vaccine mandate repeal

September 25, 2025
Prescription medicines collage: a stone mortar and pestle, scattered white tablets and capsules, and an empty blister pack
Career Development

Tylenol in the Spotlight: Pregnancy, Autism, and Evolving Guidance on Acetaminophen use

September 25, 2025
Cardiology

2 Minute Medicine Rewind October 18 – October 25, 2015

October 27, 2015
Chronic Disease

Paracetamol (Tylenol) ineffective for low-back pain [PACE Study]

July 24, 2014
Next Post
Panic disorder collage: a calm young woman breathing slowly, a teal breath ribbon, a cup of tea and a small houseplant

Patient Basics: Panic Disorder

Polycystic ovary syndrome collage: uterus and ovaries with small follicles, a blank calendar and a glucose meter

Patient Basics: Polycystic Ovary Syndrome (PCOS)

Miscarriage collage of a sprig of small white flowers, two mugs side by side and a folded knitted blanket on torn paper

Patient Basics: Miscarriage

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways
  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.